Scaling the Manufacture of ePTFE Stent Coverings: Why Clinical Requirements Outpace Manufacturing Capability
- May 4
- 18 min read
Introduction: From Bare Metal to Microstructure‑Critical Devices
The move from bare‑metal stents to covered stents—more accurately described as stent grafts—marked a genuine paradigm shift in endovascular surgery. Encapsulating a metallic scaffold, typically Nitinol or cobalt‑chromium, within a microporous polymeric membrane enables devices that can exclude aneurysms, seal perforations, reconstruct complex bifurcations, and block tissue ingrowth in hostile peripheral vascular environments. In that sense, the covering is not an accessory; it fundamentally defines the device’s indications and long‑term behavior.[1]
Among the candidate biomaterials for this role, expanded polytetrafluoroethylene (ePTFE) has become the de facto standard for permanent, long‑term cardiovascular implantation. Its fluorinated backbone handles decades of pulsatile load without hydrolytic degradation, its low surface energy and chemical inertness support acceptable blood compatibility, and its tunable node‑and‑fibril microstructure lets engineers tailor porosity to desired tissue and fluid interactions. In clinical and industrial language, “ePTFE‑covered stent” has become almost synonymous with “durable covered stent.”[2][3][1]
However, the story looks very different when you step off the cath lab floor and onto the factory floor. Scaling ePTFE stent coverings from early‑stage prototypes to commercial volumes is not simply a matter of repeating an optimized recipe. It is about wrestling with a material and process chain that are intrinsically variable: PTFE fine powder lots that differ subtly in behavior, lubricant distributions that are never perfectly uniform, paste extrusion that is sensitive to alignment and die swell, stretching that creates porosity through a controlled but chaotic fracture process, and lamination steps that can modify carefully engineered microstructure in a single thermal cycle.[4][5][6][7][8]
Clinically, physicians and device designers increasingly expect tight, reproducible control over three critical microstructural parameters:
· Internodal distance (IND), as a proxy for pore size and tissue interaction.
· Apparent density, reflecting how much solid polymer occupies a given volume.
· Wall thickness, which drives crimped profile, flexibility, and sometimes drug‑release behavior.[3][9][10][1]
In practice, because of the inherent physics of ePTFE and the statistical nature of its processing, these parameters are often realized as distributions rather than fixed values. The result is a gap between the narrow “clinical window” implied by bench and preclinical data and the broader “manufacturing window” that current processes can reliably hold at scale.[7][8][11][4]
This article takes the original five‑step process narrative—raw material and billet preparation, paste extrusion, stretching, sutureless lamination/sintering, and laser trimming—and rewrites it through the lens of this gap:
· What do clinicians and design engineers actually need in terms of IND, density, and wall thickness?
· What do typical ePTFE processes, as described in the academic and technical literature, realistically deliver today?
· Where do the tolerances of manufacturing naturally extend beyond the tolerances of biology and clinical performance?
· And, critically, what aspects of the processes might be improved to bring manufacturing capability into closer alignment with clinical requirements?
1. IND, Density, and Wall Thickness: The Clinical Spec vs. the Manufacturing Reality
Before analyzing each manufacturing step, we need to be explicit about the “specification triangle” that truly determines stent‑graft performance: IND, apparent density, and wall thickness. These are not abstract materials science curiosities; they are programmable levers that clinicians implicitly assume are tightly controlled, even when they are not.
1.1 Internodal Distance (IND): The Architect of Tissue Interaction
In ePTFE, solid polymer regions are organized into “nodes,” interconnected by fine fibrils. The distance between nodes, or internodal distance (IND), correlates strongly with effective pore size and the paths available for cellular migration and fluid flow. In practice, designers treat IND as the dominant descriptor of microstructure.[12][1][3]
From a biological standpoint, two regimes are particularly critical:
· Moderate IND (≈20–40 μm). This range is widely reported for vascular grafts that aim to support neointimal coverage without deep transmural ingrowth. Here, pore pathways are sufficient for endothelial cells and smooth muscle progenitors to colonize the luminal surface and form a relatively stable lining, but the wall still behaves largely as a barrier.[1][2][3]
· Larger IND (≈50–80 μm and up). At higher IND, microchannels become large enough for capillaries and fibrovascular tissue to traverse the graft wall. Studies using high‑porosity ePTFE with internodal distances around 60 μm demonstrate enhanced capillary and cellular ingrowth compared with lower‑porosity controls. This can create excellent anchoring and integration but may also encourage exuberant tissue ingrowth and hyperplasia at edges or anastomoses.[13][14][15][3][12]
Importantly, IND is not just a nominal design value; it is a distribution across the wall and along the length of the graft. Clinically, the assumption is that the IND distribution sits tightly within a band selected during bench and preclinical development. In a perfect world, a “30 μm IND graft” really means “most of the wall, most of the time, behaves like 30 ± a few micrometers.”[11][4][7]
Manufacturing reality is different. Because IND is created by stretching and fixed through sintering—two steps that are sensitive to temperature gradients, tension variations, and local material defects—actual IND often behaves more like “30 μm with a significant statistical spread” at scale. Industrial‑scale studies of biaxial stretching explicitly report non‑uniform microstructures across web width and length, underscoring that IND is best treated as a distribution, not a constant.[16][4][7][11]
1.2 Apparent Density: A Hidden, Coupled Variable
Apparent density of ePTFE—mass per unit volume of the porous structure—interacts with IND and wall thickness to define both mechanical and biological behavior. For a given IND, higher density implies thicker or more numerous fibrils and nodes, higher stiffness, and lower permeability; lower density implies the opposite.[8][3][1]
Clinicians rarely speak in terms of “density,” but they do experience its effects: some grafts feel firm and kink‑resistant but sluggish to expand, others feel extremely compliant but prone to collapsing under external compression. Mechanical testing of ePTFE membranes shows that tensile strength, modulus, and elongation at break all vary with density and porosity, reflecting the underlying node–fibril architecture.[3][8][1]
In engineering practice, many stent and graft designs are normalized around specific density bands, but density is strongly coupled to the chosen extrusion, stretching, and sintering conditions. Consequently, two coverings with nominally similar IND and thickness can have different densities—and thus different stiffness, recoil, and tissue ingrowth profiles—if they originate from different process windows.[8][1][3]
1.3 Wall Thickness: The Amplifier of Everything
Wall thickness is the macro‑level manifestation of microstructure. A difference of 20 or 30 micrometers in a lab sheet might sound trivial, but when that sheet is wrapped 3–5 times around a complex stent geometry, crimped and folded into a catheter, and navigated through tortuous anatomy, those micrometers multiply. Every extra layer of polymer:
· Increases the crimped outer diameter of the device.
· Changes the bending stiffness and trackability of the system.
Recent studies on drug‑eluting ePTFE stent grafts show that wall thickness directly modulates paclitaxel release, particularly at graft edges. Thicker graft walls can delay diffusion and create concentration gradients that differ from simple model assumptions, thereby shifting the device’s pharmacokinetic profile. When wall thickness is realized as a distribution with tolerances on the order of tens of micrometers, significant variability in both mechanical and pharmacological performance must be anticipated.[10][9]
From a clinical design perspective, the window of acceptable wall thickness is narrow and coupled to the French size envelope of the delivery system, the target anatomy, and, if applicable, the drug‑delivery profile. From a process perspective, that window may sit close to the natural scatter of extrusion, stretching, and lamination, making thickness a key bridge between microstructure and clinical performance.[9][10]
2. Step 1 – PTFE Raw Material and Billet Preparation: Variability at the Source
The manufacturing journey begins long before any stent enters the picture. It begins with the PTFE fine powder, the processing lubricant, and the pre‑formed billet. If this foundation is inconsistent, no amount of downstream process tuning will fully suppress variability.
2.1 Fine Powder PTFE and Lubricant: Tunable but Not Identical
PTFE fine powder for paste extrusion is produced by aqueous dispersion polymerization. Different suppliers, and even different lots from the same supplier, vary in:[6][17]
· Particle size distribution.
· Molecular weight and chain architecture.
To make the powder processable, it is blended with a hydrocarbon lubricant (such as Isopar, mineral spirits, or naphtha) to create a soft paste. The lubricant fraction typically falls in the 15–25 wt% range, tuned against the intended reduction ratio in extrusion and the rheology of the specific resin. The lubricant coats particles, reduces inter‑particle friction, and prevents premature fibrillation during early handling.[17][6]
In principle, this is all controllable. In practice:
· Slight differences in resin morphology between lots can change the way lubricant distributes and the way the powder compacts during pre‑forming.[18][5][6]
· Lubricant content is usually controlled gravimetrically across a batch but may still vary locally within the billet if mixing is not thoroughly optimized.[6][17]
· Ambient temperature affects how the paste flows and compacts; because PTFE undergoes a crystalline phase transition near room temperature, small shifts in conditioning temperature can alter its mechanical response during pre‑form and extrusion.[17][6]
From the viewpoint of IND and density, each combination of resin and lubricant content carries a slightly different propensity to fibrillate or compact, which will emerge only later under stretch.[18][5][6]
2.2 Pre‑forming: Green Density as a Predictor of Flow
The pre‑forming step compresses the powder–lubricant mixture into a solid billet under pressure, removing air and establishing a “green density.” Processing studies note that:
· Green density must be sufficiently uniform to avoid defects such as voids, delamination, or flow instabilities during paste extrusion.[19][6][17]
· Density gradients can create spots where the paste packs tightly and others where microvoids remain, setting up non‑uniform stress and shear fields in extrusion.[19][6]
From the clinical IND/density perspective, any residual inhomogeneity at this stage is a latent defect that will express itself much later as out‑of‑family pores, local stiff spots, or even ruptures during stretching. Yet because the billet is several process steps away from any clinical‑facing test, its variability often remains invisible until downstream indicators (such as yield or SEM micrographs) suggest a problem.
3. Step 2 – Paste Extrusion: The Imperfect Master of Wall Thickness
Paste extrusion is where the billet is transformed into a tube or tape with a defined wall thickness. In the canonical technical description, this is the step that “sets the wall,” while subsequent steps only thin and refine it. That is directionally true—but only to a point.
3.1 Die Geometry, Reduction Ratio, and Die Swell
The pre‑formed billet is loaded into a ram extruder and forced through a converging die. For tubular products, a mandrel defines the inner diameter; for tapes, the die produces a flat extrudate that can then be calendered. The reduction ratio (RR) expresses how aggressively the billet cross‑sectional area is reduced through the die and is a primary driver of the internal structure and mechanical properties of the “green” PTFE article.[20][6]
Key features:
· High RR aligns chains and pushes particles into closer contact, setting up the potential for strong fibrillation during stretching but also risking over‑compaction that resists expansion.[20][6]
· Die swell—where the extrudate expands as it exits the high‑pressure die environment—makes exact wall thickness prediction nontrivial. The amount of swell depends on resin, lubricant, temperature, and extrusion speed.[5][6]
· Mandrel runout and die concentricity errors on the order of tens of micrometers can translate directly into wall eccentricity and thickness variation around the circumference of the tube.[21][20]
For stent coverings made from tapes, calendering immediately after extrusion adds another layer of control and complexity.
3.2 Calendering and Draw‑down: The First Amplifier of Variation
For stent coverings made from wrapped tapes or films, the extrudate is frequently passed through heated calender rolls after exiting the die. Here, the wall thickness is ostensibly determined by the roll gap and the draw‑down tension on the web. This introduces additional sources of variation:
· Thermal expansion of the rolls changes the effective gap over time and across the roll width.
· Slight differences in tension between runs can cause the web to neck more or less, altering thickness across the width and along the length.
· Roll surface imperfections or contamination can imprint local thickness fluctuations that might later align with specific stent features.[22][21]
Clinically, designers often think in terms of a single film thickness that will wrap around the stent with essentially uniform contribution. In reality, thickness may vary gradually or locally within a single sheet.
3.3 Why Thickness Capability Lags Clinical Ambitions
From a quality‑engineering standpoint, high‑volume polymer extrusion processes can achieve high statistical capability on thickness for many materials. ePTFE, however, is particularly challenging:
· The material at extrusion is a compressible paste, not a homogeneous melt, so its flow is more sensitive to local density and shear.[5]
· Downstream stretching multiplies thickness non‑uniformities; a region thicker entering the stretch oven may not thin by exactly the same proportion as its neighbors.[4][7][11]
As a result, the practical wall thickness capability achievable for ePTFE tubes or films destined for stent coverings is often defined by the combined variability of extrusion, calendering, and stretching, rather than by any single step. Designers who envision 50 μm films with ±5 μm tolerance in mind may find that realistic, industrial‑scale processes naturally produce somewhat wider distributions unless significantly optimized.
4. Step 3 – Stretching/Expansion: The Chaotic Birth of IND
If extrusion is about geometry, stretching is about microstructure. This is the step where the extruded PTFE is heated, drawn, and transformed into a porous ePTFE with nodes and fibrils. It is simultaneously the most powerful and the most complex process in the chain.
4.1 Thermo‑Mechanical Tearing and Node–Fibril Formation
In a typical process, the extruded tube or tape is:
· Heated to drive out the lubricant without boiling it.
· Raised to a higher temperature, usually below the PTFE melting point but high enough to promote chain mobility.
During this stretch, microscopic fractures propagate through the compacted PTFE mass, transforming solid regions into nodes and interconnecting them with fibrils. The internodal distance arises from the way these fractures initiate and arrest, which is governed by:[3][7][8]
· Local stress distribution (tension, constraints, defects).
· Temperature and thermal gradients.
While it is tempting to imagine a neat, deterministic relationship between, say, a 4× stretch at a particular temperature and a 30 μm IND, the reality is closer to a statistical relationship: a given set of conditions generates a distribution of IND values whose mean and spread are influenced by all of the above.
4.2 IND: The Design Target vs. the Achievable Distribution
From a design perspective, one might define IND targets like:
· 20–30 μm for luminal surfaces intended to support thin neointimal layers without deep ingrowth.[2][3]
In preclinical and pilot‑scale manufacturing, where process parameters are tightly watched and small batch sizes permit intensive QC, it is often possible to realize IND distributions that closely align with these targets. However, as volumes scale and process robustness takes precedence, stretch conditions are chosen to produce acceptable product across an IND band rather than tightly hitting a single mean value.[16][4][7]
Industrial‑scale studies show that:
· Biaxial stretching of PTFE can produce node–fibril structures, but conventional processes tend to yield thicker centers and thinner edges (a “bowing” effect).[4][7][16]
· Microstructure uniformity requires carefully tuned roller geometry, tension control, and thermal zoning; otherwise, IND and porosity vary across the web.[7][11][4]
The net effect is that the clinically imagined window (for example, 30 ± 5 μm) translates, at scale, into an IND distribution with a somewhat larger spread. For some indications, that is tolerable; for others—particularly those involving fine‑tuned tissue responses or drug transport—the broader distribution must be explicitly accounted for.
4.3 Thickness and Density After Stretch: Coupled Variability
Stretching does not only set IND; it also reduces wall thickness and lowers apparent density. The same thermo‑mechanical behaviors that produce heterogeneity in IND also produce heterogeneity in thickness and density:
· Areas that experience slightly higher local tension may become both thinner and more expanded (larger IND, lower density).
· Areas shadowed from full heat exposure or constrained by edge effects may expand less, remaining thicker, denser, and less porous.[11][4][7]
Industrial‑scale work on ePTFE membranes explicitly comments on the challenge of achieving uniform expansion across the width and length of the web, noting non‑uniform thickness and microstructure unless carefully mitigated. Translating that into stent‑graft terms: the same process that is supposed to give a uniform 50 μm wall with 30 μm IND can produce local patches with different combinations of thickness and IND, depending on local strain and temperature histories.[4][7]
This is not a failing of any single operator; it is a consequence of using fracture‑based porosity creation in a material that responds nonlinearly to temperature and strain rate.
5. Step 4 – Sintering and Sutureless Lamination: Where Microstructure Is Won or Lost
After stretching, the ePTFE structure is thermodynamically unstable; given the opportunity, fibrils will retract and nodes will relax, shrinking the material. To stabilize the structure and simultaneously bond the covering to the stent, manufacturers perform a sintering/lamination step.
5.1 Sintering Physics: Amorphous Locking at High Temperature
Sintering involves heating the expanded PTFE above its crystalline melting point (~327 °C) and holding it there for a defined time before cooling. This step allows:
· Amorphous regions to flow and coalesce, partially fusing nodes and fibrils.
Studies on double‑expanded ePTFE and sintered membranes show that:
· Sintering temperature and time strongly affect mechanical properties such as tensile strength, modulus, and elongation.[8][4]
· Insufficient sintering can leave the structure unstable, while excessive sintering can coarsen or collapse the pore structure.[4][8]
When done correctly, sintering results in ePTFE that maintains its expanded structure during use, with minimal shrinkage and predictable mechanical behavior. However, it also modifies IND and density from the as‑stretched state.
5.2 Sintering over a stent : Pressure, Profiles, and Microstructure
Modern covered stent manufacturing typically uses Sintering over a stent : an inner ePTFE layer is placed on a mandrel, the laser‑cut stent is positioned over it, and an outer ePTFE layer is applied. A shrink tube or other radial compression mechanism is then used to press the layers together while the assembly is heated. This has two objectives:
· Fuse the ePTFE layers through the stent cells, creating a monolithic sandwich.
· Achieve a low, smooth profile that crimp and track well.
From a process standpoint, this is attractive. From an IND and wall thickness standpoint, Sintering over a stent introduces additional factors:
· The radial pressure can partially collapse the porous network, especially near metal struts where local pressure spikes are highest.[3][8]
· The composite wall thickness is not simply the sum of the inner and outer layers; it is reduced according to how much the porous structures are compressed.
· Compression and heat exposure are rarely uniform along the length and circumference of the stent.
Experimental evaluations of ePTFE membranes subjected to additional compression and heat treatments confirm that such post‑processing can reduce porosity and alter mechanical response. For devices where tissue ingrowth, flow resistance, or drug release depend sensitively on IND and porosity, understanding and controlling lamination‑induced changes become essential.[3][8]
6. Step 5 – Laser Trimming: Microns That Matter at the Edge
After lamination and sintering, the overhanging ePTFE at the stent ends must be trimmed to achieve precise edge margins. This is usually done by laser ablation. The type of laser and process control directly influence local wall thickness and porosity at the very zone that must seal against the artery wall.
6.1 Thermal Lasers vs. Ultrashort‑Pulse Lasers
Conventional CO₂ or long‑pulse lasers remove polymer by melting and vaporization, leaving behind a heat‑affected zone where the material has been thermally degraded or reflowed. For porous polymers such as ePTFE, this can:
· Collapse nearby pores and reduce IND to effectively zero at the cut line.
· Create a recast “bead” of dense PTFE, locally increasing wall thickness right at the sealing edge.
Ultrashort‑pulse (USP) lasers—picosecond and femtosecond systems—deposit energy so quickly that material is ablated by nonlinear processes with minimal heat diffusion. Properly tuned, they can cut polymers with a very narrow heat‑affected zone and limited damage to adjacent microstructure. Reviews of ultrashort‑pulse laser ablation of polymers demonstrate:[23][24][25]
· Lower ablation thresholds and higher precision.
· Much smaller thermal penetration depths compared with nanosecond pulses.
For ePTFE‑covered stents, using ultrafast lasers appropriately tuned for fluence, repetition rate, and focus position can therefore help preserve IND and thickness distributions up to the edge.
6.2 Edge Variability and Clinical Consequences
From a clinician’s view, the covered stent edge should:
· Seat flush against the vessel wall.
· Avoid sharp or bulky transitions that can traumatize endothelium.
From a microstructural viewpoint, one wants:
· IND and porosity at the edge that behave similarly to the rest of the graft.
· No dense beads or sharp micro‑steps that change local flow or tissue contact.
If the laser trimming process leaves a band of crushed, non‑porous PTFE at the edge, that may be enough to:
· Slightly increase local profile, influencing sealing and apposition.
· Present a rigid, non‑ingrowth zone that shifts tissue reaction proximally or distally.
· Interact with drug coatings at the edge in ways not captured in initial modeling.
While detailed ePTFE‑specific edge studies remain limited, general findings from polymer ablation and stent surface modification literature support the view that minimizing the heat‑affected zone and preserving microstructure near the edge are favorable for mechanical and biological performance.[26][25][23][24]
7. Why the Industry Still Needs to Improve
Across the five steps above, a theme emerges: at every point where microstructure is created or modified, there is more variability than clinicians intuitively expect and than next‑generation device concepts ideally tolerate. The existing body of clinical and materials research indicates that:
· IND, density, and thickness have meaningful effects on tissue integration, thrombosis, and drug release.[15][10][12][13][1][9][3]
· ePTFE microstructure at industrial scale is inherently statistical, with non‑uniformities across web width and along length, shaped by complex thermo‑mechanical processes.[16][7][11][8][4]
· Clinical outcome data for ePTFE‑covered versus bare‑metal stents show heterogeneity that likely reflects, among other factors, differences in device design and microstructure across products and generations.[28][27]
The gap between “textbook” clinical requirements and manufacturing reality is thus rooted in material physics and process complexity, not in any lack of effort. Nonetheless, as designs become more microstructure‑sensitive, opportunities for process improvement become increasingly important.
7.1 Clinical Designs Are Becoming Microstructure‑Sensitive
Contemporary and emerging covered stent designs rely on ePTFE microstructure not just as a static property but as an active design parameter:
· Drug‑eluting stent grafts use ePTFE thickness and porosity to shape drug diffusion profiles.[10][9]
· Advanced ePTFE membranes for stent coating are engineered for specific mechanical and porosity characteristics to balance flexibility, sealing, and tissue integration.[1][3]
· Devices intended for long dwell times in diseased vascular beds depend on carefully balanced ingrowth and barrier functions to manage restenosis, hyperplasia, and infection risks.[29][15][3]
These designs implicitly assume that IND, density, and thickness will remain within the narrow windows validated in preclinical testing. When processes at scale produce wider distributions, designers must account for that variability in their safety margins and performance expectations.
7.2 Process Capability and Robustness
Manufacturing processes for ePTFE have historically been tuned for robustness: the ability to produce acceptable product across resin lots and operating conditions, with manageable yield and throughput. For traditional grafts and coverings, this approach has produced safe and effective devices.[30][5][6]
As the field evolves, however, there is growing motivation to refine these processes so that robustness is complemented by increased precision in the three critical parameters of IND, density, and thickness. Academic work on industrial‑scale stretching and sintering provides initial guidance on how process windows could be narrowed while maintaining manufacturability.[18][7][8][4]
7.3 The Path Forward: Closing the Gap
Several development directions can help close the gap between clinical requirement and manufacturing reality:
· Material‑specific process windows. Building on stretching and sintering studies, manufacturers can develop dedicated process windows for each clinically important IND/density/thickness combination, documenting statistical capability and optimizing equipment accordingly.[7][8][4]
· Enhanced inline and near‑line metrology. Moving beyond offline SEM and occasional cross‑sections to surrogate inline measurements (optical, acoustic, or other) correlated with porosity and density would allow tighter control and earlier detection of drift.[18][11][3]
· Microstructure‑protective lamination. Designing Sintering processes explicitly to preserve IND—using lower pressure, more conformal fixtures, or tailored shrink strategies—could reduce the impact of bonding on a carefully engineered porous structure.[8][3]
· Standardizing ultrafast laser finishing. Elevating ultrashort‑pulse laser trimming from an advanced option to a more widely adopted approach for covered stent edges can help ensure that porosity and thickness remain consistent up to the sealing line.[25][23][24][26]
Ultimately, success will be measured not by how closely manufacturing can match a generic ePTFE description, but by how tightly it can deliver the specific microstructural profiles that particular clinical indications require.
Conclusion
ePTFE’s rise as the material of choice for covered stents is well deserved. Its combination of durability, relative blood compatibility, and tunable microstructure has enabled treatments that were not possible with bare metal alone. Yet the very property that makes ePTFE powerful—its programmable porosity and structure—also reveals the limits of current manufacturing practices when viewed against the increasingly precise demands of clinical design.[2][1][3]
Clinicians and device designers now think in terms of specific IND ranges, density regimes, and carefully calibrated wall thicknesses. In contrast, the processes that create ePTFE at industrial scale naturally generate statistical distributions in these parameters, shaped by the physics of paste flow, fracture‑based pore formation, and thermal consolidation.[12][13][9][10][1][5][6][7][4][3][8]
Closing the gap between clinical requirement and manufacturing reality will require treating IND, density, and wall thickness not merely as outcomes to be measured and accepted, but as critical, actively controlled design variables. It will demand new process control philosophies, improved metrology, and lamination and finishing methods designed around microstructure preservation, not just macro‑profile and adhesion.
The good news is that the path is clear: the physics of ePTFE and the available clinical and materials data already indicate the relevant windows. The challenge—and the opportunity—is to build manufacturing systems capable of consistently operating within those windows, reliably, at industrial scale.
Reference List
1. Choi ET, et al. Enhancement of Capillary and Cellular Ingrowth in ePTFE Implants with High Porosity. J Biomed Mater Res A. 2010;93(1):45–52.[12]
2. Salzmann DL, et al. The Effects of Porosity on Endothelialization of ePTFE Implanted in Subcutaneous and Adipose Tissue. J Biomed Mater Res. 1997;34(4):463–476.[31]
3. D'Angelo A, et al. Expanded Polytetrafluoroethylene Membranes for Vascular Stent Coating: Manufacturing, Biomedical and Surgical Applications, Innovations and Case Reports. Membranes (Basel). 2023;13(2):240.[1]
4. Roy‑Chaudhury P, et al. Dialysis Access Failure: A Sheep Model of Rapid Stenosis in PTFE Grafts. J Vasc Surg. 1997;25(4):702–712.[15]
5. Greenwald SE, Berry CL. Improving Vascular Grafts: The Importance of Mechanical and Haemodynamic Properties. J Pathol. 2000;190(3):292–299.[2]
6. US6939119B2. Method of Reducing the Wall Thickness of a PTFE Tube and Product Therefrom (represents technical background on PTFE tube extrusion).[21]
7. Li W, et al. Viscosity Characterization and Flow Simulation of PTFE Fine Powder Paste during Extrusion. Polymers (Basel). 2021;13(1):124.[5]
8. PTFE Fine Powder Processing Guides (e.g., Inoflon Fine Powder PTFE Processing Guide) describing aqueous dispersion polymerization and paste extrusion.[17]
9. Wang G, et al. Biaxial Stretching of Polytetrafluoroethylene in Industrial Scale to Fabricate Medical ePTFE Membrane with Node–Fibril Microstructure. Regen Biomater. 2023;10:rbad056.[16][7][4]
10. Wang G, et al. A Double‑Expanded Polytetrafluoroethylene Fabrication Method for Vascular Grafts with Improved Mechanical Properties and Biocompatibility. Membranes (Basel). 2024;14(2):article on double‑expanded ePTFE.[8]
11. Kim S, et al. Study on ePTFE with Porous and Morphological Characteristics under Different Stretching Conditions. (Journal of Membrane Science or similar).[11]
12. Optimized Microporous Structure of ePTFE Membranes by Controlling Powder Size and Stretching Conditions. J Membr Sci. 2021;620:118943.[18]
13. Zhu Q, Ye P, Niu H, et al. Effect of Expanded Polytetrafluoroethylene Thickness on Paclitaxel Release and Edge Stenosis in Stent Graft. Front Bioeng Biotechnol. 2022;10:928466.[32][10]
14. Wang X, et al. Expanded Polytetrafluoroethylene (ePTFE)‑Covered Stents Versus Bare‑Metal Stents: A Systematic Review and Meta‑Analysis. J Interv Cardiol. 2016;29(5):504–512.[27]
15. Li T, et al. Expanded Polytetrafluoroethylene‑Covered Stents Versus Bare Metal Stents for Transjugular Intrahepatic Portosystemic Shunt (TIPS): A Systematic Review and Meta‑Analysis. (Journal of Interventional Medicine, 2023).[28]
16. Sugioka K, Cheng Y. Ultrafast Lasers—Reliable Tools for Advanced Materials Processing. Light Sci Appl. 2014;3:e149.[25]
17. Nolte S, et al. Femtosecond Laser Ablation of Solids: Basics and Applications. Appl Phys A. 1997;63:109–115.[25]
18. Braren B, et al. Ultra‑Short Pulsed Laser Ablation of Polymers. Appl Surf Sci. 2001;154–155:536–540.[23][24][26]
19. Study on Microstructure Evolution and Deformation Failure Mechanism of PTFE‑Based Composites (for PTFE structure–property relationships).[33]
Comments